MARKET

CRL

CRL

Charles River Lb
NYSE

Real-time Quotes | Nasdaq Last Sale

286.14
+5.96
+2.13%
After Hours: 286.14 0 0.00% 16:58 02/26 EST
OPEN
282.05
PREV CLOSE
280.18
HIGH
288.12
LOW
277.34
VOLUME
336.40K
TURNOVER
--
52 WEEK HIGH
303.79
52 WEEK LOW
95.58
MARKET CAP
14.24B
P/E (TTM)
39.87
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Contract Research Organizations (CROs) Services Market 2020 Business Strategies, Production and Comprehensive Research Study till 2025
Feb 26, 2021 (Heraldkeepers) -- The Global Contract Research Organizations (CROs) Service Market Share is expected to exceed more than US$ 55 Billion by 2024...
Heraldkeepers · 1d ago
Global Rapid Test Kit Market with (Covid-19) Impact Analysis 2021 Challenges, Drivers, Outlook, Growth Opportunities, Forecast to 2027
Feb 26, 2021 (Heraldkeepers) -- Rapid test kits are specifically designed for use where preliminary screening test results are required and they are...
Heraldkeepers · 2d ago
Charles River signs deal to get exclusive access to Kibur Medical’s implantable microdevice
Charles River Laboratories International ([[CRL]] -2.4%) announced a partnership with Kibur Medical where Charles River gains exclusive access to Kibur’s implantable microdevice (IMD) for in vivo preclinical oncology studies.Kibur’s microdevice technology,...
Seekingalpha · 2d ago
Global Rapid Test Kit Industry Challenges, Business Overview And Forecast Research Study 2027
Heraldkeepers · 2d ago
BRIEF-Charles River Laboratories Announces Strategic Partnership With Kibur Medical To Advance Preclinical Oncology Studies
reuters.com · 2d ago
Teladoc (TDOC) Q4 Loss Widens, Revenues Surpass Estimates
Zacks.com · 2d ago
Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
Business Wire · 2d ago
Global Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), By Application (Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry), and Regional Forecasts 2020-2027
Feb 25, 2021 (Heraldkeepers) -- Global Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services) GET FREE SAMPLE...
Heraldkeepers · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CRL. Analyze the recent business situations of Charles River Lb through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CRL stock price target is 328.00 with a high estimate of 360.00 and a low estimate of 280.00.
EPS
Institutional Holdings
Institutions: 733
Institutional Holdings: 50.37M
% Owned: 101.19%
Shares Outstanding: 49.78M
TypeInstitutionsShares
Increased
180
2.98M
New
108
430.33K
Decreased
189
3.26M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.06%
Pharmaceuticals & Medical Research
-0.68%
Key Executives
Chairman/President/Chief Executive Officer/Director
James Foster
Chief Financial Officer/Executive Vice President
David Smith
Executive Vice President
William Barbo
Executive Vice President
Birgit Girshick
Executive Vice President
Joseph LaPlume
Senior Vice President/Chief Accounting Officer
Michael Knell
Lead Director/Independent Director
George Milne
Director
George Llado
Independent Director
Nancy Andrews
Independent Director
Robert Bertolini
Independent Director
Stephen Chubb
Independent Director
Deborah Kochevar
Independent Director
Martin Mackay
Independent Director
Jean-Paul Mangeolle
Independent Director
George Massaro
Independent Director
Richard Reese
Independent Director
Richard Wallman
Independent Director
Virginia Wilson
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About CRL
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.

Webull offers kinds of Charles River Laboratories Intl. Inc stock information, including NYSE:CRL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRL stock methods without spending real money on the virtual paper trading platform.